title: Antisense therapy for cancer.
abstract: Antisense molecules have the potential to halt a wide variety of diseases through inhibition of target gene expression. Five antisense phosphorothioates are currently in clinical studies for cancer therapy and encouraging early data have been presented recently.
authors.affiliation: CRC Centre for Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK. rosanne@icr.ac.uk
authors.forename: R M
authors.initials: RM
authors.lastname: Orr
authors.forename: B P
authors.initials: BP
authors.lastname: Monia